CVT-2513
| Code | Size | Price |
|---|
| TAR-T31117-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
CVT-2513 is a metabolite of Renolazine, which has anti-myocardial ischemia effect.
CAS:
162712-35-8
Formula:
C14H22N2O3
Molecular Weight:
266.341
Purity:
0.98
SMILES:
COc1ccccc1OCC(O)CN1CCNCC1
References
1. Yao Z, Gong S, Guan T, Li Y, Wu X, Sun H. Synthesis of ranolazine metabolites and their anti-myocardial ischemia activities. Chem Pharm Bull (Tokyo). 2009 Nov;57(11):1218-22. PubMed PMID: 19881270.